Polymorphisms of GSTM1 or GSTT1 alone did not correlate with risk for CCA [23] however combined polymorphisms in DNA repair and glutathione-S-transferase genes [30] were associated with reduced risk of CCA. This evidence concerns the gene HPGDS and cholangiocarcinoma.